FI920637A0 - 5-(1-aminocyklohexyl)-2(1h)-pyridinon och relaterade foereningar. - Google Patents

5-(1-aminocyklohexyl)-2(1h)-pyridinon och relaterade foereningar.

Info

Publication number
FI920637A0
FI920637A0 FI920637A FI920637A FI920637A0 FI 920637 A0 FI920637 A0 FI 920637A0 FI 920637 A FI920637 A FI 920637A FI 920637 A FI920637 A FI 920637A FI 920637 A0 FI920637 A0 FI 920637A0
Authority
FI
Finland
Prior art keywords
image
loweralkyl
hydrogen
pyridinone
aminocyclohexyl
Prior art date
Application number
FI920637A
Other languages
English (en)
Finnish (fi)
Inventor
Richard Charles Effland
David Marc Fink
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI920637A0 publication Critical patent/FI920637A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI920637A 1989-08-16 1992-02-14 5-(1-aminocyklohexyl)-2(1h)-pyridinon och relaterade foereningar. FI920637A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/394,448 US4978663A (en) 1989-08-16 1989-08-16 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
PCT/US1990/004522 WO1991002721A1 (fr) 1989-08-16 1990-08-16 5-(1-aminocyclohexyle)-2(1h)-pyridinone et composes apparentes

Publications (1)

Publication Number Publication Date
FI920637A0 true FI920637A0 (fi) 1992-02-14

Family

ID=23558997

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920637A FI920637A0 (fi) 1989-08-16 1992-02-14 5-(1-aminocyklohexyl)-2(1h)-pyridinon och relaterade foereningar.

Country Status (14)

Country Link
US (1) US4978663A (fr)
EP (1) EP0487602B1 (fr)
JP (3) JP2557568B2 (fr)
KR (1) KR927003532A (fr)
AT (1) ATE155458T1 (fr)
AU (1) AU652126B2 (fr)
CA (2) CA2063594C (fr)
DE (1) DE69031075T2 (fr)
DK (1) DK0487602T3 (fr)
ES (1) ES2109239T3 (fr)
FI (1) FI920637A0 (fr)
HU (2) HUT67589A (fr)
NO (1) NO920600L (fr)
WO (1) WO1991002721A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW473479B (en) * 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
JP5133416B2 (ja) * 2007-09-14 2013-01-30 オルソー−マクニール−ジャンセン ファーマシューティカルズ， インコーポレイテッド． １’，３’−二置換−４−フェニル−３，４，５，６−テトラヒドロ−２ｈ，１’ｈ−［１，４’］ビピリジニル−２’−オン
EP2205565B1 (fr) * 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 4-phényl-1h-pyridin-2-ones 1,3-di-substituées
ATE516272T1 (de) 2007-09-14 2011-07-15 Ortho Mcneil Janssen Pharm 1,3-disubstituierte 4-(aryl-x-phenyl)-1h-pyridin- 2-one
EP2220083B1 (fr) * 2007-11-14 2017-07-19 Janssen Pharmaceuticals, Inc. Dérivés d'imidazo[1,2-a]pyridines et leur utilisation en tant que modulateurs allostériques positifs de récepteurs mglur2
US8691849B2 (en) 2008-09-02 2014-04-08 Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CA2738849C (fr) 2008-10-16 2016-06-28 Addex Pharma S.A. Derives d'indole et de benzomorpholine en tant que modulateurs des recepteurs metabotropiques du glutamate
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5852665B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
ES2552455T3 (es) 2010-11-08 2015-11-30 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CA2815002C (fr) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. Derives 1,2,4-triazolo[4,3-a]pyridine et leur utilisation en tant que modulateurs allosteriques positifs des recepteurs mglur2
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
BR112016016390B1 (pt) 2014-01-21 2023-04-11 Janssen Pharmaceutica Nv Produto compreendendo modulador alostérico positivo do receptor glutamatérgico metabotrópico do subtipo 2 e ligante da proteína de vesícula sináptica 2a
ES2860298T3 (es) 2014-01-21 2021-10-04 Janssen Pharmaceutica Nv Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso
CN112409267A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体的制备方法
CN112409266A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903224A (en) * 1972-06-20 F. Czaja Robert Process for the production of pyridones
GB851577A (en) * 1958-03-06 1960-10-19 Parke Davis & Co Pyridine compounds and methods for producing the same
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents
JPS61165372A (ja) * 1985-01-17 1986-07-26 Daicel Chem Ind Ltd ５−ハロピリジン−３−カルボキサミド化合物
DE3823991A1 (de) * 1988-07-15 1990-02-15 Basf Ag Heterocyclisch substituierte (alpha)-aryl-acrylsaeureester und fungizide, die diese verbindungen enthalten

Also Published As

Publication number Publication date
ES2109239T3 (es) 1998-01-16
JPH09100287A (ja) 1997-04-15
HU9200461D0 (en) 1992-05-28
KR927003532A (ko) 1992-12-18
EP0487602A4 (en) 1993-03-17
NO920600D0 (no) 1992-02-14
JPH09100288A (ja) 1997-04-15
AU652126B2 (en) 1994-08-18
ATE155458T1 (de) 1997-08-15
WO1991002721A1 (fr) 1991-03-07
AU6284290A (en) 1991-04-03
EP0487602B1 (fr) 1997-07-16
CA2063594C (fr) 2002-07-16
JP2708736B2 (ja) 1998-02-04
US4978663A (en) 1990-12-18
JPH04507421A (ja) 1992-12-24
CA2063594A1 (fr) 1991-02-17
HUT67589A (en) 1995-04-28
JP2708737B2 (ja) 1998-02-04
DE69031075D1 (de) 1997-08-21
CA2332188A1 (fr) 1991-02-17
NO920600L (no) 1992-04-14
DE69031075T2 (de) 1998-02-26
DK0487602T3 (da) 1998-02-09
EP0487602A1 (fr) 1992-06-03
JP2557568B2 (ja) 1996-11-27
CA2332188C (fr) 2007-01-23

Similar Documents

Publication Publication Date Title
FI920637A0 (fi) 5-(1-aminocyklohexyl)-2(1h)-pyridinon och relaterade foereningar.
SE7908350L (sv) Nya metaboliter, framstellning och anvendning derav
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
SE7907121L (sv) Ftalimidinderivat
FI852974A0 (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
DK0461079T3 (da) Substituerede phthalider og heterocykliske phthalider
FI906045A0 (fi) Kvaevehaltiga spirocykliska foereningar.
DK0450812T3 (da) Antihypercholesterolemika
FI832930A (fi) Aptitreducerande trifluormetylfenyltetrahydropyridiner, foerfarande foer deras framstaellning och farmaceutiska kompositioner
ES2121761T3 (es) Carbamatos sustituidos de 1-(piridinilamino sustituido)-1h-indol-5-ilo, un procedimiento para su preparacion y su uso como medicamentos.
SE7910151L (sv) Bensoxadiazoler och benstiadiazoler
EP0251014A3 (en) 2-trifluoromethyl benzimidazoles
MA19604A1 (fr) Procede de preparation de nouvelles triazoloquinazolones et leurs sels
HUT42277A (en) Herbicides containing as active subtance derivatives of new 1-aryl-4-nitro-pirasole and process for production of the active substances
ES503920A0 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
SE8506125L (sv) 8alfa-acylaminoergoliner, deras framstellning och farmaceutiska kopositioner innehallande dessa
FI913799A (fi) 1-(pyridinylalkyl)-1h-indoler, indoliner och med dem beslaektade analoger.
DK177783A (da) Organosilylforbindelser og fungicider indeholdende saadanne forbindelser
FI902851A0 (fi) 4,5,5a,6-tetrahydro-3h-isoxazolo/5,4,3 -kl/akridinderivat, foerfarande foer deras framstaellande och deras anvaendning som laekemedel.
SE7704033L (sv) Oxotiaforeningar
ES506947A0 (es) Mejoras introducidas en un procedimiento para la preparacion hidroximidatos y tiolhidroximidatos heterobiciclicos y de- rivados ester carbomatos de los mismos.
ZA832824B (en) New therapeutically useful dithiino (1,4)(2,3-c)pyrrole derivatives